作者: Edward E. Partridge , Jerri Linn Phillips , Herman R. Menck
DOI: 10.1002/(SICI)1097-0142(19961115)78:10<2236::AID-CNCR28>3.0.CO;2-Z
关键词:
摘要: Background Epithelial ovarian cancer continues to challenge clinicians. There is no accepted method of screening for cancer, and most patients present with advanced disease. In spite advances in surgery chemotherapy, survival be poor. Methods The data, comprising the caseloads 940 hospitals, are from National Cancer Data Base. 15,254 patients, diagnosed 1988 or 1993, had prior diagnosis. Results quality improved by 1993; 89.4% records included American Joint Committee on (AJCC) staging information compared 67.9% 1988. Borderline epithelial tumors germ cell were commonly found younger women more likely at Stage I. percentage carcinoma treated only increased substantially 1993. Relative decreased increasing tumor stage grade. Five-year was considerably lower (38%) than either borderline (95%) (86%). addition chemotherapy treatment I did not improve outcome, nor dramatic improvement brought about II III low grade Chemotherapy beneficial disease, Grade 3 4, IV Conclusions Most cancers continue No improvements early detection apparent reference years studied. benefits this disease obvious those These less clear However, there significant room diagnosis